Side effects of taking tirzepatide: what the evidence shows

What the trial data actually recorded

SURMOUNT-1 enrolled 2,539 adults over 72 weeks and produced some of the most detailed safety data available for any weight-management medicine. The majority of side effects were gastrointestinal in nature: nausea, diarrhoea, vomiting and constipation were the most frequently reported across all dose groups. Indigestion, burping and reflux also appeared, particularly during the early weeks. Most participants who experienced these effects described them as mild to moderate, and they usually settled once the body had time to adapt to each dose level.

Fatigue, headache and dizziness were reported less often but are acknowledged in the official guidance. Injection-site reactions (mild redness or tenderness where the pen was used) occurred in a smaller proportion of participants. The SURMOUNT programme's findings are discussed in detail in NICE's technology appraisal of tirzepatide (TA1026), which informed its recommendation for use in the UK.

One pattern worth understanding: side effects from tirzepatide do not stay constant throughout treatment. They often reappear briefly after each dose increase, then settle again. This is why titration happens gradually, giving your system time to adjust rather than jumping straight to a higher strength.

Side effects that need prompt medical attention

If you're reading this page, you may already be weighing up whether treatment is right for you, and that's a completely reasonable thing to think carefully about. Some side effects are uncommon but serious, and it matters that you know what to watch for.

Acute pancreatitis is one. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting pancreatitis as an infrequent but potentially serious risk. The warning sign is severe, persistent stomach pain that may spread towards the back, sometimes accompanied by vomiting. Stop taking the medicine and seek urgent medical help if this happens.

Gallbladder problems (including gallstones) have also been reported with tirzepatide. Symptoms to watch for include upper-right abdominal pain, fever and yellowing of the skin or whites of the eyes. Dehydration from persistent vomiting or diarrhoea can place strain on the kidneys, so staying well hydrated and contacting your prescriber if you cannot keep fluids down matters too.

Signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, widespread rash) require emergency care. And if you experience sudden or worsening changes to your vision, contact a healthcare professional promptly. A full list of symptoms requiring attention is included in the Patient Information Leaflet supplied with your pen.

What managing day-to-day side effects looks like in practice

For most people, the practical experience of tirzepatide is manageable rather than dramatic. Eating smaller portions, choosing lower-fat foods and avoiding lying down immediately after meals can reduce nausea during the adjustment period. Staying hydrated helps with constipation. The starting dose of 2.5mg exists for a reason: it gives your digestive system time to adapt before the prescriber considers moving to a higher strength.

Tirzepatide slows gastric emptying, which is central to how it reduces appetite but is also the mechanism behind most of the GI effects. If you want to understand exactly what to expect from the medicine, our page on tirzepatide side effects covers each category in more depth, including how frequently different effects were recorded across trial doses.

If a side effect is affecting your day-to-day life, contact your prescriber rather than stopping treatment abruptly. A pause or a slower titration schedule may be all that's needed. At nume, our clinical team provides priority aftercare seven days a week precisely because these conversations shouldn't have to wait.

Reporting side effects and finding further guidance

The MHRA's Yellow Card scheme lets anyone (patients and carers included) report a suspected side effect from a medicine. Reporting matters: it is how post-market safety signals are identified and acted on. You can do so at yellowcard.mhra.gov.uk. Your prescriber will also want to know about any significant effects you experience, so keep a note of when they started, how long they lasted and how severe they were.

For a fuller picture of how tirzepatide works and the broader evidence around its safety, the tirzepatide safety overview on this site covers contraindications, monitoring and who the medicine is not suitable for. Our Mounjaro treatment page sets out the consultation process and what clinical assessment involves, and if you want a detailed look at the side effects of taking Mounjaro specifically, that page covers the branded medicine's profile in full. If you have specific questions about whether your own medical history affects your suitability, speaking to our prescribers as part of a free consultation is the right place to start, and any concerns about tirzepatide side effects on mood form a central part of every review we carry out.